Richmond, Virginia, September 1, 2022 /PRNewswire/ — Indivior PLC’s (LON: INDV) September is National Recovery Month to educate people about substance use disorders (SUDs) and the effectiveness of evidence-based treatment and counseling to make recovery possible. It’s time to let people know.
Substance use disorders are chronic diseases that affect a person’s brain and behavior, resulting in uncontrolled use of substances such as legal and illegal drugs, alcohol, and medicines.1 It is also an epidemic disease. The latest preliminary data released by the U.S. Centers for Disease Control and Prevention (CDC) reportedly killed more than 104,000 people in a 12-month drug overdose. March 202278,828 of these deaths are due to illicit opioids such as fentanyl.2
“At Indiva, we are committed to helping people who suffer from substance use disorders break the vicious cycle of addiction,” he said. Christian Hydebleder, Chief Scientific Officer. “By reducing stigma, increasing access to evidence-based treatment, and normalizing substance use disorders as a disease, we can bring more people into active recovery and help them get their lives back. I can do it.”
Despite defining addiction as a disease in the last two decades, improving our understanding of how addiction affects the brain, and advocating for evidence-based treatment, recent estimates suggest that many people do not benefit from drug therapy. It is suggested that only 13.4% of people nationwide have the potential. You can have Opioid Use Disorder (MOUD).3 People in urgent need of help are often unaware of treatment options, have limited access to treatment and counseling, or are unwilling to seek it out of fear of stigma.Four Lack of access to treatment continues to widen the treatment gap, especially among underserved and marginalized communities.Five
“Recovery from substance use disorders is possible,” he said. terry horton, MD, FACP, FASAM, Vice President, Indivior Patient Insights and Advocacy. “But advocacy and patient support are very important,” he continued. “As stakeholders, our policy response to the opioid epidemic should aim to normalize treatment and classify addiction like any other chronic disease. We can transform, provide resources, and get them to those who need them most.”
Indivior envisions a future where the stigma of addiction is removed and evidence-based SUD treatments are accessible to manage SUD like any other chronic disease.
Learn more about National Recovery Month here.
Indivior is a global pharmaceutical company that helps transform patients’ lives by developing medicines to treat substance use disorders (SUDs) and serious mental illnesses. Our vision is that all patients worldwide have access to evidence-based treatment for the chronic disease and comorbidities of SUD. Indivior is dedicated to transforming SUD from a global human crisis into a recognized and treatable chronic disease. Building on our global portfolio of OUD treatments, Indivior expands on this category’s heritage and is designed to potentially address other chronic and comorbid disorders of SUD, including alcohol use disorders and cannabis use disorders. We have a pipeline of product candidates. Headquartered in Richmond, Virginia, USA, Indivior employs over 900 people worldwide and its product portfolio is available in over 40 countries worldwide.visit www.indivior.com you can know more.to connect with Indivior on LinkedIn www.linkedin.com/company/indivior.
1. Psychiatric disorders comorbid with substance use. (n.d.). National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health#:%7E:text=A%20substance%20use%20disorder%20(SUD,drugs%2C%20alcohol% ) 2C%20or%20 drugs
2. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm, go to August 24, 2022
3. Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerdá M. Has the U.S. Opioid Use Disorder Treatment Gap Narrowed?: An Annual Review from 2010 to 2019″. Int J Drug Policy. 2022 Jul 19: 103786. Epub before print.
Four. National Drug Control Strategy, White House, Office of National Drug Control Policy, 2022
Five. National-Drug-Control-2022Strategy.pdf (whitehouse.gov)
6. Nida. 2021, August 31stThe drug overdose deaths of 2020 were horrific. A fundamental change is needed to address the drug crisis. Retrieved from https://www.drugabuse.gov/about-nida/noras-blog/2021/08/drug-overdose-deaths-in-2020-were-horrifying-radical-change-needed-to-address-drug- crisis